Rock Springs Capital Management »

Corcept Therapeutics Incorporated shares owned by Rock Springs Capital Management

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Rock Springs Capital Management from 13F filings

Historical chart of Rock Springs Capital Management investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Rock Springs Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Rock Springs Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.7M 50k 34.80

More positions owned by Rock Springs Capital Management

Eli Lilly & Co. (LLY)
Revolution Medicines (RVMD)
Argenx Se Sponsored Adr (ARGX)
Travere Therapeutics (TVTX)
Madrigal Pharmaceuticals (MDGL)
Rhythm Pharmaceuticals (RYTM)
EXACT Sciences Corporation (EXAS)
Mirum Pharmaceuticals (MIRM)
Insmed Com Par $.01 (INSM)
Structure Therapeutics Sponsored Ads (GPCR)
Intuitive Surgical Com New (ISRG)
Cidara Therapeutics Com New (CDTX)
Ascendis Pharma A/s Sponsored Adr (ASND)
Irhythm Technologies (IRTC)
Kymera Therapeutics (KYMR)

View all positions for Rock Springs Capital Management

Top funds holding Corcept Therapeutics Incorporated

BlackRock
Vanguard Group
Ingalls & Snyder
Renaissance Technologies
Parallel Advisors
State Street Corporation
Geode Capital Management
UBS Group
FMR
Dimensional Fund Advisors
AQR Capital Management
Caption Management
Charles Schwab Investment Management
TD Asset Management
Susquehanna International

View all funds holding Corcept Therapeutics Incorporated